Other cancer drugs in discovery, clinical trial or market phase, including AGPH's MMP inhibitor, do not ENTIRELY block tumor growth, and do not eradicate advanced cancer (i.e, > 5% body weight tumor mass) in mice. IF (!) ES/AS combo can do this in people, AND it can be manufactured at acceptable cost and in sufficient quantities, AND no similarly efficacious and safe drug appears on the horizon, ALL the others (cancer drugs, companies, revenues, stock) will be eliminated. At once. Those who fall will include the "almost as good as ES/AS angiogenesis inhbitors", even ENMD's other project, thalidomide. The best treatment beats the others and takes over the market in the cancer business. Sorry.
StockDoc |
